Thursday, 29 June 2017

India News

  • Challenge No 5: Talent trouble

    India |  Analysis | By Narayan Kulkarni | 0 Comment | 17 May, 2012

    Lack of trained and skilled workforce, identifying a market-savvy work force and retaining the right people on key positions are problems in certain regions, especially for conducting R&...Read more

  • India to be Asia Pacific region hub for QED

    India |  Influencers | By Vipul Murarka | 0 Comment | 06 Jun, 2012

    UK-headquartered QED Clinical Services, recently, enhanced its global delivery of clinical trials by creating a wholly owned subsidiary - QED Clinical Services India - in Ahmedabad, India....Read more

  • Jubilant Biosys collaborates with Sanofi to develop metabolic disorders therapy

    India |  News | By BioSpectrum Bureau | 0 Comment | 11 Jan, 2016

    Singapore: India based Jubilant Biosys, subsidiary of Jubilant Life Sciences, and Germany based Sanofi Deutschland have announced a strategic alliance to discover and develop small molecule...Read more

  • Sun-Ranbaxy deal clears first regulatory hurdle

    India |  News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2014

    Singapore: The $4 billion merger of Ranbaxy Laboratories with Sun Pharmaceutical Industries has received clearance from two of India's leading stock exchanges, BSE and NSE. This has removed...Read more

  • Funding start-ups is a huge concern in India

    India |  Opinion | By BioSpectrum Bureau | 0 Comment | 13 Nov, 2012

    The life sciences sector has been to a large extent insulated from the recession that cast a long shadow on the industry. Having said that, the industry has its own set of challenges.The si...Read more

  • New diabetes drug to save upto Rs 10,000 a year on treatment

    India |  News | By BioSpectrum Bureau | 0 Comment | 15 Jun, 2015

    Singapore: Now diabetes patients can heave a sigh of relief with India-based Glenmark Pharma announcing the launch of Teneligliptin, that promises to lower treatment cost for patients by 55...Read more

  • India inks health pact with the US

    India |  News | By BioSpectrum Bureau | 0 Comment | 26 Jun, 2015

    Singapore: India and the United States of America (USA) have signed Memorandums of Understanding (MoUs) on Cooperation on Cancer Research, Prevention, Control, Management and Collaboration ...Read more

  • India biotech rides on biologics manufacturing

    India |  News | By BioSpectrum Bureau | 0 Comment | 07 Mar, 2012

    A large chunk of the Indian firms are also looking at contract manufacturing of biologic products for western companies. The contract manufacturing organization (CMO) market is a growing ma...Read more

  • Arvind Remedies signs MoU to launch new drugs

    India |  News | By BioSpectrum Bureau | 0 Comment | 14 Jul, 2014

    Singapore: Arvind Remedies, a producer of branded and generic pharma products has entered into a Memorandum of Understanding (MoU) with Adesh University, Bhatinda, Punjab. As per the unders...Read more

  • Crossed $1 Billion mark

    India |  Analysis | By BioSpectrum Bureau | 0 Comment | 02 Jul, 2015

    Singapore:  Dr Reddy's Laboratories, India Chairman: Mr Satish ReddyRevenue: $2273.4MNBusiness: Produces and markets finished dosage forms, active ingredients and biosimilar products Clo...Read more

  • Designing organisms: The science of synthetic biology

    India |  Opinion | By BioSpectrum Bureau | 0 Comment | 27 Sep, 2012

    DNA sends the coded message to RNA for the onward transmission of message to proteins. For a long time people thought that once the 'DNA tap' is open, the message will flow out uniformly. N...Read more

  • Mylan's capacity will rise to 50 bn doses in APAC during 2012

    India |  Influencers | By Manasi Vaidya | 0 Comment | 09 Oct, 2012

    Mylan was recently chosen as the leading supplier of antiretroviral (ARV) drugs to India's National AIDS Control Organization (NACO),a division of India's Ministry of Health and Family Welf...Read more

  • Ranbaxy launches authorized generic of Evoxac

    India |  News | By BioSpectrum Bureau | 0 Comment | 10 Oct, 2012

    Hyderabad: Ranbaxy Pharmaceuticals launched the authorized generic cevimeline hydrochloride 30 mg capsules in the US market, under an agreement with Daiichi Sankyo. Cevimeline hydrochlori...Read more

  • India biotech to be $125 billion gorilla by 2025

    India |  Analysis | By Narayanan Suresh | 0 Comment | 01 Oct, 2012

    ...Read more

  • India to issue guidelines to regulate antibiotic usage

    India |  News | By BioSpectrum Bureau | 0 Comment | 08 Sep, 2015

    Singapore: A senior WHO official said that India will soon issue guidelines to regulate the use of antibiotics and their prescription. Speaking at a Media workshop a day before the 68TH Se...Read more

  • Malpractices in Indian drug approval system exposed

    India |  Analysis | By Manasi Vaidya | 0 Comment | 17 Aug, 2012

    India received a lot of criticism in the past few months after a report exposed malpractices in the functioning of Central Drugs Standards Control Organization (CDSCO). The report by the pa...Read more

  • Bayer CropScience India gets new MD

    India |  News | By BioSpectrum Bureau | 0 Comment | 31 Jan, 2014

    Mumbai: The board of directors of Bayer CropScience India, at a recently held meeting in Mumbai on January 30, 2014, appointed Mr Richard van der Merwe as the managing director and vice cha...Read more

  • Bloopers made by Indian Drug Standards Control organization

    India |  Analysis | By Manasi Vaidya | 0 Comment | 17 Aug, 2012

    The report of the Indian parliamentary standing committee that focuses on the functioning of the Central Drugs Standards Control Organization, is finally out. Read the excerpts and the argu...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls